The U.S. Department of Health and Human Services announced it will decertify Network for Hope, a Kentucky-based organ procurement organization, following allegations that staff continued with organ retrieval procedures despite patients showing signs of life, including a case where a patient was thrashing, crying, and shaking his head.
A secret shopper investigation of 49 websites prescribing GLP-1 weight loss drugs confirmed experts' concerns about inadequate clinical oversight and fast, easy prescriptions with minimal medical evaluation.
U.S. health officials have appointed doctors and pharmacists with deep financial connections to the peptide industry to an FDA advisory panel that will reconsider controversial peptide drugs next month. The appointments raise ethics concerns given the panelists could benefit from regulatory changes they help shape.
Multiple hospitals have received federal grand jury subpoenas regarding gender-affirming care for minors, indicating the Department of Justice has begun a criminal investigation into these medical practices.
